Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors

BACKGROUND AND OBJECTIVES: To clinically characterize post–immune checkpoint inhibitor (ICI) Hu antibody (Ab) neurologic disorders, we analyzed Hu-Ab–positive patients with neurologic immune-related adverse events (n-irAEs) and compared them with patients with other n-irAEs, ICI-naive patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Farina, Antonio, Villagrán-García, Macarena, Ciano-Petersen, Nicolás Lundahl, Vogrig, Alberto, Muñiz-Castrillo, Sergio, Taillandier, Luc, Michaud, Maud, Lefilliatre, Mathilde, Wang, Adrien, Lepine, Zoe, Picard, Géraldine, Wucher, Valentin, Dhairi, Maroua, Fabien, Nicole, Goncalves, David, Rogemond, Véronique, Joubert, Bastien, Honnorat, Jèrôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709718/
https://www.ncbi.nlm.nih.gov/pubmed/36446613
http://dx.doi.org/10.1212/NXI.0000000000200058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709718/
https://www.ncbi.nlm.nih.gov/pubmed/36446613
http://dx.doi.org/10.1212/NXI.0000000000200058

Ejemplares similares